Affy Stock Slides 13 Percent on Weak Q2 as Banks Downgrade Shares and Temper Outlook

Aug 01, 2006

NEW YORK (GenomeWeb News) – Shares in Affymetrix were down approximately 13 percent, or $2.72, at $18.85 in mid-afternoon trading today after the company yesterday posted a $10.1 million net loss and a 4.7-percent decline in revenue for the second quarter.

The stock is currently trading at levels not seen since 2003.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Cell Count

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

Varied Opinions

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

Marine Mammal Gene Loss

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

This Week in PNAS

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Main menu